Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Inventory (2022 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Change in Inventory for 4 consecutive years, with -$170000.0 as the latest value for Q1 2025.

  • Quarterly Change in Inventory rose 65.31% to -$170000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$170000.0 through Dec 2025, up 84.77% year-over-year, with the annual reading at -$170000.0 for FY2025, 84.77% up from the prior year.
  • Change in Inventory for Q1 2025 was -$170000.0 at Whitehawk Therapeutics, down from -$158000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $2.2 million in Q4 2023, with the low at -$630000.0 in Q3 2024.
  • Average Change in Inventory over 4 years is $295384.6, with a median of $7000.0 recorded in 2022.
  • Peak annual rise in Change in Inventory hit 861.39% in 2023, while the deepest fall reached 4700.0% in 2023.
  • Over 4 years, Change in Inventory stood at $1.1 million in 2022, then skyrocketed by 97.43% to $2.2 million in 2023, then tumbled by 107.1% to -$158000.0 in 2024, then fell by 7.59% to -$170000.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$170000.0, -$158000.0, and -$630000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.